Researchers are studying the effectiveness of drugs for treating COVID-19 in cancer patients who have been infected with the coronavirus.

by Marcus A. Banks

An FDA committee votes to recommend holding off on approval of an immunotherapy for early-stage triple-negative breast cancer, and physicians warn that enlarged lymph nodes after COVID-19 vaccination can be mistaken for signs of breast cancer.

by Kate Yandell

Fecal transplants may improve immunotherapy responses, and more than half of cancer survivors have at least one additional condition that increases their risk of severe COVID-19.

by Kevin McLaughlin

Advocates are asking that cancer patients be prioritized for COVID-19 vaccination, and a KRAS inhibitor shows promising phase II trial results.

by Kate Yandell

People are using crowdsourced fundraising to cover cancer care costs, and missed cancer screenings due to COVID-19 may have led to fewer missed diagnoses than feared.

by Kevin McLaughlin

The Cancer Today editorial staff selects some of the most impactful reporting and essays of 2020.

by Cancer Today Staff

Researchers estimate that breast cancer surpassed lung cancer as the most commonly diagnosed cancer globally in 2020, and a study provides insight into financial toxicity's impact on quality of life.

by Bradley Jones

The San Antonio Breast Cancer Symposium and American Society of Hematology meeting go virtual, and COVID-19 brings silver linings to cancer clinical trials.

by Marci A. Landsmann

Many people who pursue low-dose CT lung cancer screening do not follow the recommended screening schedule, and U.K. scientists say the COVID-19 pandemic has set back progress in cancer research.

by Kevin McLaughlin

Researchers investigate why some patients respond exceptionally well to cancer treatment, and the Food and Drug Administration approves a second immunotherapy drug for some breast cancer patients.

by Kate Yandell